Radial Endothelial Striae Over 360 Degrees in Fuchs Corneal Endothelial Dystrophy: New Pathophysiological Findings.


Journal

Cornea
ISSN: 1536-4798
Titre abrégé: Cornea
Pays: United States
ID NLM: 8216186

Informations de publication

Date de publication:
01 Dec 2021
Historique:
received: 18 10 2020
accepted: 10 12 2020
pubmed: 17 2 2021
medline: 11 1 2022
entrez: 16 2 2021
Statut: ppublish

Résumé

To report evidences that the abnormal endothelium of some Fuchs endothelial corneal dystrophy (FECD) present centripetal radial lines over 360 degrees. A case report of retroilluminated pictures of 2 patients with FECD and flat mounts of isolated Descemet membranes of 1 patient with FECD and of 1 healthy donor. Interpretation and development of a new pathophysiological theory. The 3 FECD images unequivocally demonstrate the existence of very numerous radial centripetal lines over 360 degrees, in the central 8 to 9 mm of the cornea and ending in the area of maximum guttae concentration. These lines resemble, in a much longer length, the physiological striae that we described in 2012 at the periphery of the endothelium of normal corneas. We suppose that these lines reflect an accelerated migration of a population of pathological endothelial cells that deposit collagen on their path before being slowed down and then blocked in the center, explaining the progressive accumulation of guttae in this area. This new migration theory assumes that FECD behaves as a corneal endothelial stem-cell disease.

Identifiants

pubmed: 33591033
doi: 10.1097/ICO.0000000000002666
pii: 00003226-202112000-00016
doi:

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1604-1606

Informations de copyright

Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Déclaration de conflit d'intérêts

The authors have no funding or conflicts of interest to disclose.

Références

Ong Tone S, Kocaba V, Bohm M, et al. Fuchs endothelial corneal dystrophy: the vicious cycle of Fuchs pathogenesis. Prog Retin Eye Res. 2021;80:100863 [epub ahead of print].
Sharp JAH, Matsou A, Stanojcic N. Peripheral endothelial radial lines in Fuchs endothelial dystrophy. Ophthalmology. 2020;127:1019.
He Z, Campolmi N, Gain P, et al. Revisited microanatomy of the corneal endothelial periphery: new evidence for continuous centripetal migration of endothelial cells in humans. Stem Cells. 2012;30:2523–2534.
Okumura N, Kitahara M, Okuda H, et al. Sustained activation of the unfolded protein response induces cell death in Fuchs' endothelial corneal dystrophy. Invest Ophthalmol Vis Sci. 2017;58:3697–3707.
Katikireddy KR, Schmedt T, Price MO, et al. Existence of neural crest-derived progenitor cells in normal and Fuchs endothelial dystrophy corneal endothelium. Am J Pathol. 2016;186:2736–2750.
Lobo EP, Delic NC, Richardson A, et al. Self-organized centripetal movement of corneal epithelium in the absence of external cues. Nat Commun. 2016;7:12388.
Whikehart DR, Parikh CH, Vaughn AV, et al. Evidence suggesting the existence of stem cells for the human corneal endothelium. Mol Vis. 2005;11:816–824.
Mimura T, Joyce NC. Replication competence and senescence in central and peripheral human corneal endothelium. Invest Ophthalmol Vis Sci. 2006;47:1387–1396.
Yamagami S, Yokoo S, Mimura T, et al. Distribution of precursors in human corneal stromal cells and endothelial cells. Ophthalmology. 2007;114:433–439.
McGowan SL, Edelhauser HF, Pfister RR, et al. Stem cell markers in the human posterior limbus and corneal endothelium of unwounded and wounded corneas. Mol Vis. 2007;13:1984–2000.
Lagali NS, Stenevi U, Claesson M, et al. Donor and recipient endothelial cell population of the transplanted human cornea: a two-dimensional imaging study. Invest Ophthalmol Vis Sci. 2010;51:1898–1904.
Jacobi C, Zhivov A, Korbmacher J, et al. Evidence of endothelial cell migration after Descemet membrane endothelial keratoplasty. Am J Ophthalmol. 2011;152:537–542.e2.
Moloney G, Chan UT, Hamilton A, et al. Descemetorhexis for Fuchs' dystrophy. Can J Ophthalmol. 2015;50:68–72.
Moloney G, Petsoglou C, Ball M, et al. Descemetorhexis without grafting for Fuchs endothelial dystrophy-supplementation with topical ripasudil. Cornea. 2017;36:642–648.
Macsai MS, Shiloach M. Use of topical rho kinase inhibitors in the treatment of Fuchs dystrophy after Descemet stripping only. Cornea. 2019;38:529–534.
Artaechevarria Artieda J, Wells M, Devasahayam RN, et al. 5-year outcomes of Descemet stripping only in Fuchs dystrophy. Cornea. 2020;39:1048–1051.
Moloney G, Garcerant Congote D, Hirnschall N, et al. Descemet stripping only supplemented with topical ripasudil for Fuchs endothelial dystrophy 12-month outcomes of the Sydney Eye Hospital Study. Cornea. 2020 [epub ahead of print].
Garcerant D, Hirnschall N, Toalster N, et al. Descemet's stripping without endothelial keratoplasty. Curr Opin Ophthalmol. 2019;30:275–285.

Auteurs

Gilles Thuret (G)

Corneal Graft Biology, Engineering and Imaging Laboratory, BiiGC, EA2521, Federative Institute of Research in Sciences and Health Engineering, Faculty of Medicine, Jean Monnet University, Saint-Etienne, France.
Department of Ophthalmology, University Hospital, Saint-Etienne, France; and.

Anthony Ain (A)

Corneal Graft Biology, Engineering and Imaging Laboratory, BiiGC, EA2521, Federative Institute of Research in Sciences and Health Engineering, Faculty of Medicine, Jean Monnet University, Saint-Etienne, France.

Noriko Koizumi (N)

Department of Biomedical Engineering, Doshisha University, Kyotanabe, Japan.

Naoki Okumura (N)

Department of Biomedical Engineering, Doshisha University, Kyotanabe, Japan.

Philippe Gain (P)

Corneal Graft Biology, Engineering and Imaging Laboratory, BiiGC, EA2521, Federative Institute of Research in Sciences and Health Engineering, Faculty of Medicine, Jean Monnet University, Saint-Etienne, France.
Department of Ophthalmology, University Hospital, Saint-Etienne, France; and.

Zhiguo He (Z)

Corneal Graft Biology, Engineering and Imaging Laboratory, BiiGC, EA2521, Federative Institute of Research in Sciences and Health Engineering, Faculty of Medicine, Jean Monnet University, Saint-Etienne, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH